Effects of C358A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase on weight loss and cardiovascular risk factors 1 year after biliopancreatic diversion surgery.

de Luis, D A; Sagrado, M Gonzalez; Pacheco, D; Terroba, M C; Martin, T; Cuellar, L; Ventosa, M

de Luis, D A; Sagrado, M Gonzalez; Pacheco, D; Terroba, M C; Martin, T; Cuellar, L; Ventosa, M.

Affiliation

de Luis DA; Center of investigation of Endocrinology and Clinical Nutrition, University of Valladolid Medical School and Unit of Investigation, Hospital Rio Hortega, Valladolid, Spain. dadluis@yahoo.es

Surg Obes Relat Dis ; 6(5): 516-20, 2010.

Article in En | MEDLINE | ID: mdl-20870184

Subject(s)

Amidohydrolases/genetics; Biliopancreatic Diversion; Cannabinoid Receptor Modulators/genetics; Cardiovascular Diseases/genetics; Endocannabinoids; Obesity, Morbid/genetics; Obesity, Morbid/surgery; Polymorphism, Genetic; Adult; Alleles; Body Mass Index; Comorbidity; Female; Genetic Predisposition to Disease; Genotype; Humans; Lipids/blood; Male; Risk Factors; Statistics, Nonparametric; Weight Loss/genetics

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polymorphism, Genetic / Obesity, Morbid / Cardiovascular Diseases / Biliopancreatic Diversion / Endocannabinoids / Cannabinoid Receptor Modulators / Amidohydrolases Type of study: Etiology_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: Surg Obes Relat Dis Journal subject: METABOLISMO Year: 2010 Document type: Article Affiliation country: Spain Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google